Therapeutic potential of mesenchymal stem cells producing interferon-alpha in a mouse melanoma lung metastasis model. - Wikidata - wikimedia - TriplyDB

Therapeutic potential of mesenchymal stem cells producing interferon-alpha in a mouse melanoma lung metastasis model.

Therapeutic potential of mesenchymal stem cells producing interferon-alpha in a mouse melanoma lung metastasis model.

http://www.wikidata.org/entity/Q34133208

about

Mesenchymal Stem Cell-Mediated Effects of Tumor Support or Suppression Immunotherapeutic organoids: a new approach to cancer treatment Mesenchymal Stem Cells Induce Epithelial to Mesenchymal Transition in Colon Cancer Cells through Direct Cell-to-Cell Contact.The promising potential of menstrual stem cells for antenatal diagnosis and cell therapy Systemically Infused Mesenchymal Stem Cells Show Different Homing Profiles in Healthy and Tumor Mouse Models Targeting of mesenchymal stem cells to ovarian tumors via an artificial receptor.Trafficking mesenchymal stem cell engraftment and differentiation in tumor-bearing mice by bioluminescence imaging.Genetic engineering of mesenchymal stem cells and its application in human disease therapy.PhiC31/PiggyBac modified stromal stem cells: effect of interferon γ and/or tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) on murine melanoma.The effects of mesenchymal stem cells injected via different routes on modified IL-12-mediated antitumor activity.The effect of Kisspeptin-10 on mesenchymal stem cells migration in vitro and in vivo.Potential of Mesenchymal Stem Cell based application in Cancer Influence of mesenchymal stem cells on metastasis development in mice in vivo Efficient co-expression of bicistronic proteins in mesenchymal stem cells by development and optimization of a multifunctional plasmid.The pro-metastatic role of bone marrow-derived cells: a focus on MSCs and regulatory T cells Drug-releasing mesenchymal cells strongly suppress B16 lung metastasis in a syngeneic murine model.Effect of targeted ovarian cancer therapy using amniotic fluid mesenchymal stem cells transfected with enhanced green fluorescent protein-human interleukin-2 in vivo.Mesenchymal stem cells engineered for cancer therapy A specific subpopulation of mesenchymal stromal cell carriers overrides melanoma resistance to an oncolytic adenovirus Therapeutic effects of bone marrow mesenchymal stem cells expressing interleukin-12 in mice bearing malignant ascites tumor.Mesenchymal stem cells as a novel vaccine platform.CCR2-dependent recruitment of macrophages by tumor-educated mesenchymal stromal cells promotes tumor development and is mimicked by TNFα PTEN-mRNA engineered mesenchymal stem cell-mediated cytotoxic effects on U251 glioma cells Concise review: mesenchymal stem cells and translational medicine: emerging issues.To grab the stroma by the horns: from biology to cancer therapy with mesenchymal stem cells Mesenchymal stem cells modified to express lentivirus TNF-α Tumstatin(45-132) inhibit the growth of prostate cancer.Tumor immunotherapy using gene-modified human mesenchymal stem cells loaded into synthetic extracellular matrix scaffolds.Type I interferons exert anti-tumor effect via reversing immunosuppression mediated by mesenchymal stromal cells.Co-culture of hepatoma cells with hepatocytic precursor (stem-like) cells inhibits tumor cell growth and invasion by downregulating Akt/NF-κB expression.Adenovirus-mediated delivery of the human IFN-γ gene potentiates the cytotoxicity of daunorubicin against leukemic cells through downregulation of the α4β1 integrin/ILK/apoptosis pathway.Quantification of B16 melanoma cells in lungs using triplex Q-PCR--a new approach to evaluate melanoma cell metastasis and tumor control.Advanced new strategies for metastatic cancer treatment by therapeutic stem cells and oncolytic virotherapy.The application of mRNA-based gene transfer in mesenchymal stem cell-mediated cytotoxicity of glioma cells.Mesenchymal stem cells: a new trend for cell therapy.Non-invasive cell tracking in cancer and cancer therapy.Stem cells as vectors for antitumour therapy.Mesenchymal-stem-cell-based experimental and clinical trials: current status and open questions.Non-hematopoietic stem cells as factories for in vivo therapeutic protein production.Bio-inspired, bioengineered and biomimetic drug delivery carriers.Multipotent mesenchymal stromal cell therapy and risk of malignancies.

P2860

Q26773413-BF091B44-E391-4F07-BAF6-928D4E6918EE Q26853431-48D225A2-5CB1-4769-A5C5-5180C2379AA7 Q33595542-9CB88DFB-2F05-4B7E-BE51-52CBCBDBC606 Q33658078-91814A26-BD1C-4DB2-8531-EC06D356ED33 Q33722638-7E9CCA93-8F7C-4AF8-8FFF-D032058D8958 Q33907262-FF2ADE79-690E-41C7-AAE7-3D8D0A7C667D Q34164696-C57E1861-19F2-4132-99AD-0A82287A484D Q34298871-7E7577DB-1165-4645-BFE4-50B69CB0A25B Q34649457-FB5E45C8-914C-40EB-9FFE-68F3BA42C64A Q35073652-BB39ACF0-71BB-41C8-B9C8-767036C07D12 Q35098108-C0CE7F79-47A4-4A7C-B390-33F95BD054ED Q35540034-89DA24CC-6836-4CCC-BBD8-1347D17946BE Q35556013-188824B4-4DAE-4072-AC14-8C9CE8792B77 Q35579268-C319F64E-0D56-4DA3-B390-7FDC82C4963B Q35931795-78AF0B9E-67B6-48E2-9819-3B9D22AB77EC Q35945960-3BECC704-D09B-4CC0-8E9A-6CFA195AD543 Q36089746-2F5BEE41-3581-4FE7-96F4-2BEAD6FB39B2 Q36092724-B799FB63-6C88-4239-9F6E-CF367C5E7939 Q36225368-C9AAA131-B94B-4606-B2D7-657444DC7FBC Q36317710-BF98CA9A-2599-4B2D-BA46-898AC3F4E70D Q36404011-D6FAA1F7-6D3D-4590-999D-46A48111223D Q36456715-25563DDF-D8EA-45CB-9A33-C58DD03A0160 Q36742113-15DD49C0-B136-411D-87DA-58353587710D Q37056276-1D4676D8-A64A-40CB-9CC0-2C13F514FD0D Q37093530-DD99A3FD-0200-4BC2-BCAE-7DF3187639BB Q37294534-B7FB92CD-BAB0-4E95-BDE0-F68F88FF9B1F Q37312523-846AD85B-3943-4F3E-8CCE-F952AB4BE06A Q37365677-6C6BFB81-249E-4E02-82CC-780CD770084E Q37407300-30C3ED5C-6AF8-436B-B880-AE112B6554E3 Q37438021-2070D999-072C-45C0-A926-6CF5A07A8E37 Q37539163-ABC3EEC1-45F8-42DF-8A45-6786EAE47D0E Q37629088-2EFB194F-9EB9-4F6D-A142-F578AC3F4674 Q37688267-546BCBB2-EE2D-4683-B9FB-288592C59766 Q37729093-ACEA9576-5DD6-4A06-8157-2A064A36D660 Q37730165-64458A8B-6EDA-4329-B7A3-59C45F2251A8 Q37730300-CD04C5D3-5DCF-4961-A0A2-D0972DF5EE8E Q37859370-A44819F4-92F2-4E92-A82B-F8B3261EE2E7 Q37874445-A6B08BC8-FD59-408C-8F3A-0068983C5695 Q37896455-3D25C2FF-F854-47E7-BAA9-4CA47015A895 Q37975113-47668C2A-1D05-4E0F-9289-E2317A87269E

P2860

Therapeutic potential of mesenchymal stem cells producing interferon-alpha in a mouse melanoma lung metastasis model.

http://www.wikidata.org/entity/Q34133208

description

2008 nî lūn-bûn

@nan

2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Therapeutic potential of mesen ...... elanoma lung metastasis model.

@ast

Therapeutic potential of mesen ...... elanoma lung metastasis model.

@en

Therapeutic potential of mesen ...... elanoma lung metastasis model.

@nl

type

label

Therapeutic potential of mesen ...... elanoma lung metastasis model.

@ast

Therapeutic potential of mesen ...... elanoma lung metastasis model.

@en

Therapeutic potential of mesen ...... elanoma lung metastasis model.

@nl

prefLabel

Therapeutic potential of mesen ...... elanoma lung metastasis model.

@ast

Therapeutic potential of mesen ...... elanoma lung metastasis model.

@en

Therapeutic potential of mesen ...... elanoma lung metastasis model.

@nl

P1433

Q34133208-47D041D3-25D3-4478-BE78-9E49541FA798

P1476

Q34133208-5DFFD935-69FE-4D61-B19C-CFD5AF21505F

P2093

Q34133208-5E0C062C-7583-4079-9FED-952B1A55DB54

Q34133208-5F8A0258-AF28-43C7-9337-0594B372CCE2

Q34133208-6DFB2C62-DF5F-4D7B-868F-9F4FFF735C3C

Q34133208-A0E0D144-DCA5-4589-ACF5-584E8D4A9235

Q34133208-A7B465D7-C327-48E7-B0E8-54BE7E0C0BEF

Q34133208-ED273B49-31B2-4555-B7F0-3FA61200F9C2

P2860

Q34133208-09CD5171-30AF-460D-8D72-82711A923C28

Q34133208-1335044E-D5C0-4B4B-A3FA-3B9069C2DE54

Q34133208-1909C135-BFDB-427A-AB76-27BAC8319879

Q34133208-2199BD84-0719-4A3A-95E1-2F07C1689CE7

Q34133208-27C85FC4-C137-4B91-A027-B2AE6343D641

Q34133208-28832708-E3AE-41E0-BD7C-90E853F095B5

Q34133208-34E94D91-5A94-47A3-B01E-30808B6A0F22

Q34133208-3DFBB55E-6607-4C45-86F7-E46C7A4F1AC8

Q34133208-4DE9D8DA-31DC-4451-9B1F-0D0F122E4831

Q34133208-681E4631-B6B6-431F-A8B9-EDBF2D070243

P304

Q34133208-80DE1C97-2687-4872-9A3D-733219818BF8

P31

Q34133208-53AED8AF-6E63-488E-886D-D3E189D4222D

P356

Q34133208-5565D462-5DD3-47A1-BF8B-F633487DAB15

P433

Q34133208-A1D67BB5-2EB0-435C-B70B-345ABF186283

P478

Q34133208-F9616185-FFFA-4412-AFC6-7F30523733A4

P577

Q34133208-2476379B-5FAD-4122-BFA2-4E96D28BF1CD

P5875

Q34133208-EBACC06D-44A8-4620-B3ED-1A1ABCCE2A87

P698

Q34133208-D4A73C71-7ADF-4F80-9C69-CA2C2B81FF58

P932

Q34133208-046E912D-0637-4309-AA48-15A095E7DAA5

P356

STEMCELLS.2008-0084

P1433

P1476

Therapeutic potential of mesen ...... elanoma lung metastasis model.

@en

P2093

Changchun Ren

http://www.w3.org/2001/XMLSchema#string

Diptiman Chanda

http://www.w3.org/2001/XMLSchema#string

Jian Chen

http://www.w3.org/2001/XMLSchema#string

John D Mountz

http://www.w3.org/2001/XMLSchema#string

Sanjay Kumar

http://www.w3.org/2001/XMLSchema#string

Selvarangan Ponnazhagan

http://www.w3.org/2001/XMLSchema#string

P2860

Mesenchymal stem cells avoid allogeneic rejection

Host microenvironment in breast cancer development: inflammatory cells, cytokines and chemokines in breast cancer progression: reciprocal tumor-microenvironment interactions

Multilineage potential of adult human mesenchymal stem cells

Putting tumours in context

Side effects of interferon-alpha therapy

Interferons and their actions

Neuropsychiatric side effects of interferon-alfa therapy.

Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells.

Interferons: pleiotropic cellular modulators.

Mesenchymal stem cells: clinical applications and biological characterization.

P304

2332-2338

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1634/STEMCELLS.2008-0084

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P577

2008-07-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5234348

http://www.w3.org/2001/XMLSchema#string

P698

18617688

http://www.w3.org/2001/XMLSchema#string

P932

2940717

http://www.w3.org/2001/XMLSchema#string